Education
2021 - 2022
2021 - 2022Post Doctorate
Universitat Autonoma de Barcelona, Vall D' Hebron Research Institute, Protein Kinase in Cancer Lab, Spain
2019 - 2019
2019 - 2019Post Doctorate
The National Research Council of Italy, Institute of clinical physiology (IFC), Toscano Tumor Core Research Laboratory Research Unit, Italy
2009 - 2015
2009 - 2015Doctorate
Akdeniz University, Tıp Fakültesi / Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik Anabilim Dalı (Tıbbi Genetik), Turkey
2007 - 2009
2007 - 2009Postgraduate
Akdeniz University, Tıp Fakültesi / Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik Anabilim Dalı (Tıbbi Genetik), Turkey
2003 - 2007
2003 - 2007Undergraduate
Hacettepe University, Fen Fakültesi, Biyoloji, Turkey
Dissertations
2015
2015Doctorate
İnsülin Sinyal İletiminde p38 Kinaz Rolünün Araştırılması
Akdeniz University, Tıp Fakültesi, Tıbbi Biyoloji Ve Genetik
2009
2009Postgraduate
Borderline Yüzey Epitel Over Tümörlerinde Mitokondriyal Mikrosatellit Profilinin Belirlenmesi
Akdeniz University, Tıp Fakültesi, Tıbbi Biyoloji Ve Genetik
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Medical Biology
Internal Medicine Sciences
Medical Genetics
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2021 - Present
2021 - PresentAssociate Professor
Van Yüzüncü Yil University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2018 - 2021
2018 - 2021Assistant Professor
Van Yüzüncü Yil University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2019 - 2019
2019 - 2019Assistant Professor
--Seçiniz--, Consiglio Nazionale Delle Ricerche, Toscano Tumor Core Research Laboratory Research Unit
2016 - 2018
2016 - 2018Assistant Professor
Van Yüzüncü Yil University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2015 - 2016
2015 - 2016Research Assistant PhD
Van Yüzüncü Yil University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2011 - 2015
2011 - 2015Research Assistant
Akdeniz University, Faculty Of Medicine, Tıbbi Biyoloji Ve Genetik Anabilim Dalı
2014 - 2014
2014 - 2014Other
Eberhard Kals Universitaet Tübingen, Interfaculty Institute Of Biochemistry, Transgenic Mouse Models And Signal Transduction Laboratory
Managerial Experience
2022 - Present
2022 - PresentHead of Department
Van Yüzüncü Yil University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2017 - Present
2017 - PresentAcademic Council Member of Department
Van Yüzüncü Yil University
2019 - 2023
2019 - 2023Erasmus Program Institutional Coordinator
Van Yüzüncü Yil University
2018 - 2020
2018 - 2020Assistant Coordinator
Van Yüzüncü Yil University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2017 - 2017
2017 - 2017Member of the Commission
Van Yüzüncü Yil University
Non Academic Experience
2016 - Present
2016 - PresentKurucu Ortak
GENOVAN Genetik - Biyoteknoloji Ar-Ge Danışmanlık, Kurucu Ortak
2021 - 2022
2021 - 2022Doktora sonrası Araştırmacı
Autonomous University of Barcelona/Vall D'Hebron Research Institute, Doktora sonrası Araştırmacı
2019 - 2019
2019 - 2019Ziyaretçi Araştırmacı
Consiglio Nazionale delle Ricerche, Toscano Tumor Core Research Laboratory Research Unit, Ziyaretçi Araştırmacı
2014 - 2014
2014 - 2014Ziyaretçi Doktora Öğrencisi
Tubingen University, Interfaculty of Institute of Biochemistry, Ziyaretçi Doktora Öğrencisi
Supervised Theses
2024
2024Expertise In Medicine
Bariatrik cerrahi hastalarında fto gen polimorfizmlerinin kilo kaybı ile arasındaki ilişki
Görgişen G. (Co-Advisor), Çelik S.
E.Şentürk(Student)
2023
2023Doctorate
Production of black instant tea powder and evaluation of its physicochemical and anticancer properties
Görgişen G. (Co-Advisor), Öztop H. M.
N.EZGİ(Student)
2022
2022Doctorate
UCP2 Ala55Val ve -866G>A Polimorfizmlerinin Bariatrik CerrahiSonrası Kilo Verme İle İlişkisi
Görgişen G. (Co-Advisor), Kaptanoğlu S.
S.ÖZTAŞ(Student)
2021
2021Postgraduate
Meme kanseri hücre hattında insülin reseptörü substratı 1 (IRS1) indüklü miRNA ekspresyon profilinin belirlenmesi
Görgişen G. (Advisor)
Y.ECER(Student)
2021
2021Postgraduate
Glioblastoma multiforme' de IRS4 proteininin radyoterapi üzerindeki rolünün belirlenmesi
Görgişen G. (Advisor)
A.ARSLAN(Student)
2020
2020Postgraduate
IRS1 Gly972Arg ve IRS2 Gly1057Asp Polimorfizmlerinin Gastrik Kanser Gelişimi ile Arasındaki İlişki
Görgişen G. (Advisor)
U.Karataş(Student)
2019
2019Postgraduate
İn vitro ortamda insülin reseptör substrat 1 (IRS1) bağımlı sinyal iletim ağının glioblastoma multiforme gelişimindeki rolünün belirlenmesi
Görgişen G. (Advisor)
Z.YAREN(Student)
2017
2017Postgraduate
INVESTIGATION OF THE CYTOTOXIC, GENOTOXIC AND APOPTOTIC INFLUENCES OF PENTAMIDINE ISETHIONATE IN BREAST CANCER
Görgişen G. (Co-Advisor)
H.Hussein(Student)
Articles
All (34)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (21)
Scopus (26)
TRDizin (6)
Other Publications (6)
2025
20251. Valorization of Black Tea Waste Fibers into Instant Teas and Characterization of Their Bioactive Profile and Physicochemical Properties
ÇİFTE N. E., Taskin E., Görgişen G., Namli S., Yetgin M. M., Gurleyik A., et al.
ACS Food Science and Technology
, vol.5, no.1, pp.162-174, 2025 (Scopus)
2025
20252. Comprehensive Bioinformatical Analysis of Association of IGFL2 Expression and Methylation Profiles with Prognosis of Head and Neck Cancer
Görgişen G., Yabalak S.
Eastern Journal of Medicine
, vol.30, no.1, pp.22-28, 2025 (Scopus, TRDizin)
2024
20243. The Role of Insulin Receptor Substrate 4 (IRS4) Protein in the Radiotherapy Response of Glioblastoma Multiforme (GBM) Cells
Arslan A., Çakır T., Görgişen G.
Pharmata , vol.4, no.4, pp.102-106, 2024 (Peer-Reviewed Journal)
2024
20244. The relationship between Fc epsilon receptor-1a and β (FCER1A and FCER1B) gene polymorphisms in patients with chronic urticaria using omalizumab
Savas H., Ozkol H. U., Görgişen G., Özkol H., Ateş C., Metin A., et al.
Postepy Dermatologii i Alergologii
, vol.41, no.4, pp.357-363, 2024 (SCI-Expanded)
2023
20235. The Molecular Prevalence of Blastocystis spp. in Patients with Diarrhea Ishalli hastalarda Blastocystis spp. Yayginliǧi
Beyhan Y. E., Görgişen G.
Gazi Medical Journal
, vol.34, no.2, pp.133-136, 2023 (Scopus)
2022
20226. The ERK5/NF-kappa B signaling pathway targets endometrial cancer proliferation and survival
Dieguez-Martinez N., Espinosa-Gil S., Yoldi G., Megias-Roda E., Bolinaga-Ayala I., Vinas-Casas M., et al.
CELLULAR AND MOLECULAR LIFE SCIENCES
, vol.79, no.10, 2022 (SCI-Expanded, Scopus)
2022
20227. The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives
Görgişen G., Aydin M., Mboma O., Goekyildirim M. Y., Chao C.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, vol.23, no.17, 2022 (SCI-Expanded, Scopus)
2022
20228. Association of insulin-like growth factor binding protein-7 promoter methylation with esophageal cancer in peripheral blood
Kaya Z., Almal N., Sahin E. S., Duran S., Görgişen G., ATEŞ C.
MOLECULAR BIOLOGY REPORTS
, vol.49, no.5, pp.3423-3431, 2022 (SCI-Expanded, Scopus)
2022
20229. Role of Sedative-Hypnotic Agents in Neurodegeneration: Effects of Midazolam and Thiopental on Apoptosis and Oxidative Stress Expression in Neonatal and Adult Rat Brains
Soyalp C., Oksuz E., Görgişen G., Gülaçar İ. M., Yaşar S., Tuncdemir Y. E., et al.
TURKISH NEUROSURGERY
, vol.32, no.3, pp.378-385, 2022 (SCI-Expanded, Scopus)
2022
202210. Relationship between MTHFR Gene Polymorphisms and Gastrointestinal Tumors Development: Perspective from Eastern Part of Turkey
Oksuz E., Görgişen G., Oto G., Özdemir H., Aras A., Oksuz M., et al.
JOURNAL OF INVESTIGATIVE SURGERY
, vol.35, no.1, pp.83-91, 2022 (SCI-Expanded, Scopus)
2021
202111. No Association Between IRS2 Gly1057Asp Polymorphism and Esophageal Cance
Gülaçar İ. M., Kaya Z., Almalı N., Ateş C., Yeşil Sayın G., Görgişen G.
Van Sağlık Bilimleri Dergisi , vol.14, no.3, pp.298-303, 2021 (Peer-Reviewed Journal)
2021
202112. Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles.
Cetin Z., Saygili E. I., Görgisen G., Sokullu E.
Stem cell reviews and reports
, vol.17, pp.471-501, 2021 (SCI-Expanded, Scopus)
2021
202113. Effect of Paracetamol in the Proliferation of Glioblastoma Cell Line: The Role of Apoptosis, COX-2 and Cyclin B Expressions
Oksuz E., Görgişen G., Özdemir H., Gülaçar İ. M., Oto G.
TURKISH NEUROSURGERY
, vol.31, no.1, pp.46-50, 2021 (SCI-Expanded, Scopus)
2021
202114. Evaluation of TP53 codon 72 polymorphism in esophageal cancer susceptibility in Eastern Anatolia region of Turkey
Kaya Z., Almalı N., Karan B. M., Görgişen G.
Eastern Journal of Medicine
, vol.26, no.3, pp.388-395, 2021 (Scopus, TRDizin)
2020
202015. PROTEIN GENE EXPRESSION PROFILING OF YERSINIA RUCKERI ISOLATES GROWN AT DIFFERENT TEMPERATURES
Önalan Ş., Görgişen G., Ergoz B.
Fresenius Environmental Bulletin , vol.29, no.12, pp.11677-11684, 2020 (SCI-Expanded, Scopus)
2020
202016. Silibinin and ellagic acid increase the expression of insulin receptor substrate 1 protein in ultraviolet irradiated rat skin.
Gorgisen G., Ozkol H., Tuluce Y., Arslan A., Ecer Y., Keskin S., et al.
Biotechnic & histochemistry : official publication of the Biological Stain Commission
, vol.95, no.8, pp.641-646, 2020 (SCI-Expanded, Scopus)
2020
202017.
Görgişen G., Ecer Y., Arslan A., Algül S., Oto G., Kaya Z.
Ortadoğu Tıp Dergisi
, vol.12, no.2, pp.306-312, 2020 (TRDizin)
2020
202018. Association of IRS1 Gly972Arg and IRS2 Gly1057Asp polymorphisms with gastric cancer in Turkish subjects
Görgişen G., Karataş U., Ateş C., Öksüz M., Gülaçar İ. M.
Oncology Letters
, vol.20, pp.1-5, 2020 (SCI-Expanded, Scopus)
2020
202019. p38 MAPK Attenuates Insulin Signaling by Inhibiting IRS1 Tyrosine Phosphorylation in IRS1 Overexpressed 293T Cells
Görgişen G., Özeş O. N.
Van Health Sciences Journal , vol.13, no.1, pp.19-24, 2020 (Peer-Reviewed Journal)
2020
202020. Insulin receptor substrate 1 overexpression promotes survival of glioblastoma cells through AKT1 activation.
Gorgisen G., Yaren Z.
Folia neuropathologica
, vol.58, pp.38-44, 2020 (SCI-Expanded, Scopus)
2019
201921. Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.
Gorgisen G., HAPIL F., YILMAZ O., CETIN Z., PEHLIVANOGLU S., OZBUDAK I., et al.
Genetics and molecular biology
, vol.42, pp.15-25, 2019 (SCI-Expanded, Scopus)
2019
201922. Overexpression of insulin receptor substrate 1 (IRS1) promotes radioresistance in A172 glioblastoma cell line
Görgişen G., Çakır T., Ateş C., Gülaçar İ. M., Yaren Z.
Eastern Journal of Medicine
, vol.24, no.2, pp.204-209, 2019 (Scopus, TRDizin)
2019
201923. Effect of acetaminophen on viability of hela cells
Görgişen G., Gülaçar İ. M., Öksüz E.
Eastern Journal of Medicine
, vol.24, no.1, pp.53-56, 2019 (Scopus)
2018
201824. Antiproliferative and Apoptotic Role of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) Benzenesulfonamide in Common Cancer Models.
Tuluce Y., Gorgisen G., Gulacar I., Koyuncu I., Durgun M., Akocak S., et al.
Anticancer research
, vol.38, pp.5115-5120, 2018 (SCI-Expanded, Scopus)
2018
201825. İnsülin direncinde İnsülin Reseptör Substrat 1 Proteininin Rolü
Görgişen G.
BOZOK TIP DERGİSİ , vol.8, no.3, pp.114-121, 2018 (TRDizin)
2018
201826. Role of IRS1 in Insulin Resistance and Cancer
Görgişen G., Özeş O. N.
Journal Of Immunological Science
, vol.2, no.4, pp.8-14, 2018 (Peer-Reviewed Journal)
2017
201727. The effects of melatonin on oxidative stress and prevention of primordial follicle loss via activation of mTOR pathway in the rat ovary.
Behram K., AYDIN C., Gorgisen G.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.63, pp.100-106, 2017 (SCI-Expanded, Scopus)
2017
201728. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation.
Gorgisen G., Gulacar I., OZES O.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.63, pp.1-5, 2017 (SCI-Expanded)
2016
201629. Differential actıvation and expression of insulin receptor substrate 1 (IRS1) in mononuclear cells of type 2 diabetes patients after insulin stimulation.
Gorgisen G., Balci M. K., Celik F. C., Gokkaya M., Ozdem S., Ozel D., et al.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.62, no.2, pp.25-30, 2016 (SCI-Expanded, Scopus)
2014
201430. Personalized Treatment Options in Non-Small Cell Lung Cancer
Görgişen G., PEHLIVANOGLU S., OZES D., OZES O.
Receptors and Clinical Investigations
, vol.1, no.1, pp.189-199, 2014 (Peer-Reviewed Journal)
2014
201431. Novel and rare CFTR gene mutations in Turkish patients with congenital aplasia of vas deferens
Akin Y., Demir D., Görgişen G., Lüleci G., ALPER Ö., Watanabe C., et al.
Andrologia
, vol.46, no.2, pp.198-199, 2014 (SCI-Expanded, Scopus)
2013
201332. Differential expression and activation of Epidermal Growth Factor Receptor 1 (EGFR1), ERK, AKT, STAT3, and TWIST1 in nonsmall cell lung cancer (NSCLC)
Gorgisen G., Ozes D., Pehlivanoglu S., ERDOĞAN A., DERTSİZ L., ÖZBİLİM G., et al.
Experimental Lung Research
, vol.39, no.9, pp.387-398, 2013 (SCI-Expanded, Scopus)
2012
201233. Induced expression and activation of oncogenes in NSCLC (non-small cell lung cancer) in the absence of activating mutations of EGFR and k-Ras
Gorgisen G., Ozes D., Pehlivanoglu S., ERDOĞAN A., DERTSİZ L., ÖZBİLİM G., et al.
CANCER RESEARCH
, vol.72, 2012 (SCI-Expanded, Scopus)
2011
201134. Böbrek Kanserinin Moleküler Temeli
OZES O., OZES D., PEHLIVANOGLU S., Görgişen G.
Türkiye Klinikleri Nefroloji Dergisi
, vol.4, no.1, pp.1-9, 2011 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. A PAN-CANCER ANALYSIS OF THE EXPRESSION AND PROGNOSTIC SIGNIFICANCE OF IGFBP6 IN HEAD AND NECK CANCER
Yatalak S., Görgişen G.
EURASIA II. INTERNATIONAL CONGRESS OF HEALTH SCIENCES, Baku, Azerbaijan, 1 - 02 January 2025, pp.1, (Summary Text)
2025
20252. A PAN-CANCER ANALYSIS OF FUS: INVESTIGATING ITS LINK TO LIVER HEPATOCELLULAR CARCINOMA
Karakoç S., Görgişen G.
EURASIA II. INTERNATIONAL CONGRESS OF HEALTH SCIENCES, Baku, Azerbaijan, 1 - 02 January 2025, pp.1, (Summary Text)
2024
20243. BIOINFORMATIC ANALYSIS OF EXPRESSION AND METHYLATION STATUS OF MAPK15 IN KIDNEY RENAL CLEAR CELL CARCINOMA
Yabalak S., Görgişen G.
3rd INTERNATIONAL PARIS CONGRESS ON MEDICAL & HEALTH SCIENCES, Paris, France, 1 - 03 July 2024, pp.291, (Summary Text)
2024
20244. ASSOCIATION BETWEEN UCP2 - 866G>A POLYMORPHISM AND POSTBARIATRIC SURGERY WEIGHT LOSS: A STUDY IN TURKEY
Öztaş S., Kaptanoğlu S., Özalp İ., Şentürk E., Kızıltan R., Görgişen G.
12. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS, Gaziantep, Turkey, 29 - 31 May 2024, pp.122-123, (Summary Text)
2024
20245. Identification of IGFL2 Protein as a Potential Prognostic Biomarker in Head and Neck Cancer using Bioinformatical Approaches
Görgişen G., Yabalak S.
2nd nternational Congress of Multidisciplinary Medical and Health Sciences Studies, Ankara, Turkey, 27 - 28 May 2024, pp.91, (Summary Text)
2024
20246. Determination of Ectopic Insulin Receptor Substrate 1 (IRS1) Induced miRNA Profile in Breast Cancer Development
Ecer Y., Görgişen G.
13th International Academic Studies Conference, Ankara, Turkey, 22 - 24 May 2024, pp.329-330, (Summary Text)
2024
20247. The Role of Insulin Receptor Substrate 4 (IRS4) Protein in the Radiotherapy Response of Glioblastoma Multiforme
Arslan A., Çakır T., Görgişen G.
4th International Aegean Health Areas Symposium 2024, İzmir, Turkey, 7 - 08 March 2024, pp.34-35, (Summary Text)
2021
20218. Meme Kanseri Hücre Hattı Üzerinde Gümüş Nanopartiküllerin Radyoterapi Duyarlılığı
Çakır T., Karakaya C., Görgişen G., Gülaçar İ. M., Tunçel N.
18. Ulusal Medikal Fizik Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.55, (Summary Text)
2020
20209. RADIOTHERAPY SENSITIVITY AND CELL PROLIFERATION OF BREAST CANCER CELL LINE USED BENZOXAZOLONE DERIVED CHALCONE COMPOUND
Çakır T., Görgişen G., Bilginer S., Gül H. İ.
3rd International Medicine and Health Sciences Researches Congress, Ankara, Turkey, 13 - 15 March 2020, pp.209-215, (Full Text)
2019
201910. Insulin Receptor Substrate 1 (IRS1) Gly972Arg Polymorphism in Gastric Cancer
Görgişen G., Karataş U., Ateş C., Öksüz M.
VII. International Symposium on Academic Studies in Health and Sport Science, Ankara, Turkey, 15 - 17 November 2019, pp.13, (Summary Text)
2019
201911. İnsülin-benzeri büyüme faktörü bağlayıcı protein 7 ekspresyonu ve özofagus kanseri arasındaki ilişki
KAYA Z., ALMALI N., TÜLÜCE Y., ÖZKOL H., GÖRGİŞEN G.
Tıbbi Biyloji ve Genetik Kongresi (Uluslararası Katılımlı), Muğla, Turkey, 27 - 30 October 2019, (Summary Text)
2019
201912. INSULIN RECEPTOR SUBSTRATE 1 (IRS1) SIGNALING IN CANCER PROGRESSION AND THERAPY
Görgişen G.
Eurosian Congress on Molecular Biotechnology, Trabzon, Turkey, 19 - 21 September 2019, pp.42, (Full Text)
2019
201913. S636, S666 AND S736 PHOSPHORYLATIONS OF INSULIN RECEPTOR SUBSTRATE 1 (IRS1) DECREASE THE VIABILITY OF HELA CELLS VIA INHIBITING TYROSINE PHOSPHORYLATION OF IRS1
GÖRGİŞEN G., GÜLAÇAR İ. M., TÜLÜCE Y., ÖZKOL H., KAYA Z.
International Conference on Recent Advances in Medical Science (ICRAMS), Krakow, Poland, 13 - 14 September 2019, (Summary Text)
2019
201914. Evaluation of anticancer activity of synthesized silver nanoparticles using zingerber officinale extract
Aydin Acar C., Görgişen G.
3rd International Congress on Advances in Bioscience and Biotechnology, Kiev, Ukraine, 10 - 14 July 2019, pp.22, (Summary Text)
2019
201915. Site Specific Serine Phosphorylation of insulin receptor substrat 1 (IRS1) protein inhibit the proliferation of cervical carcinoma cells
Görgişen G., Gülaçar İ. M., Tülüce Y., Özkol H., Kaya Z.
XXVI. International Symposium on Morphological Sciences, Praha, Czech Republic, 5 - 07 July 2019, pp.26-27, (Summary Text)
2019
201916. Protein gene expression profiling of Yersinia ruckeri isolates grown at different temperatures
Önalan Ş., ERGÖZ B., Görgişen G.
4th INTERNATIONAL CONFERENCE ON ADVANCES IN NATURAL & APPLIED SCIENCES, Ağrı, Turkey, 19 - 22 June 2019, vol.1, no.1, pp.1, (Summary Text)
2019
201917. PARACETAMOL INHIBITS INSULIN RECEPTOR SUBSTRATE 1 PROTEIN ACTIVATION IN GLIOBLASTOMA CELL LINE
Görgişen G., Öksüz E., Aydin Acar C.
International Symposium on Academic Studies in Health and Sport Sciences, Ankara, Turkey, 15 - 17 June 2019, pp.23, (Summary Text)
2018
201818. EFFECTS OF INSULIN RECEPTOR SUBSTRATE 1 (IRS1) PROTEIN ON CELL PROLIFERATION AND THERAPEUTIC APPROACHES IN DIFFERENT CANCER CELL LINES"
Görgişen G., Gülaçar İ. M., Çakır T.
International Symposium on Multidisciplinary Studies, Ankara, Turkey, 16 - 17 November 2018, pp.728-729, (Summary Text)
2018
201819. Association of rs1042522 and rs3176352 polymorphisms with esophageal cancer
KAYA Z., KARAN B. M., ALMALI N., GÖRGİŞEN G., TÜLÜCE Y., ÖZKOL H.
1st INTERNATIONAL CONFERENCE OF GENOMICS AND BIOINFORMATICS (ICGB - 2018), Aydın, Turkey, 1 - 04 November 2018, pp.38, (Summary Text)
2018
201820. Serine Phosphorylation of insulin receptor substrate 1 (IRS1) protein inhibit the proliferation of cervical carcinoma cells
GÖRGİŞEN G., GÜLAÇAR İ. M., TÜLÜCE Y., ÖZKOL H., KAYA Z.
XXVI. International Symposium on Morphological Sciences, Prague, Czech Republic, 5 - 07 July 2018, (Summary Text)
2018
201821. SITE SPECIFIC SERINE PHOSPHORYLATION OF INSULIN RECEPTOR SUBSTRATE 1 (IRS1) PROTEIN INHIBITS THE PROLIFERATION OF CERVICAL CARCINOMA CELLS
Görgişen G., Gülaçar İ. M., Tülüce Y., Özkol H., Kaya Z.
XXVI International Symposium on Morphological Sciences, Prag, Czech Republic, 5 - 07 July 2018, pp.70, (Full Text)
2018
201822. Genomic Medicine in Cancer
Görgişen G.
1st International Health Science and Life Congress, Burdur, Turkey, 2 - 05 May 2018, pp.1, (Full Text)
2017
201723. Meme Kanserinde Pentamidin İzetiyonat’ın Sitotoksik, Genotoksik ve Apoptotik Etkilerinin Araştırılması
ÖZKOL H., BESOKY H. H., GÖRGİŞEN G., KOYUNCU İ., TÜLÜCE Y., KAYA Z.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi (Uluslararası katılımlı), 26 - 29 October 2017, (Summary Text)
2017
201724. Meme Kanserinde Pentamidin İzetiyonat' ın Sitotoksik, Genotiksik ve Apoptotik Etkilerinin Araştırılması
Özkol H., Besoky H. H., Görgişen G., Koyuncu İ., Tülüce Y., Kaya Z.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi (Uluslararası Katılımlı), Muğla, Turkey, 26 - 29 October 2017, pp.1, (Full Text)
2017
201725. The effects of melatonin oxidative stress and prevention primordial follicle loss via activation of mTOR pathway in rat ovary
Behram Kandemir Y., Aydin Acar C., Görgişen G.
European Human Genetics Congress, Copenhagen, Denmark, 27 - 30 May 2017, (Full Text)
2017
201726. Anti-Proliferative Effect of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl) Triaz-1-en-1-yl) Benzenesulfonamide on Common Gynecological Cancer Cell Lines
TÜLÜCE Y., GÖRGİŞEN G., GÜLAÇAR İ. M., KOYUNCU İ., DURGUN M., AKOCAK S., et al.
VI. International Congress of Molecular Medicine, 22 - 25 May 2017, (Summary Text)
2017
201727. GENOMIC MEDICINE IN PANCREATIC CANCER
Görgişen G., Gülaçar İ. M.
Innovation in Medicine Summit 3, Gaziantep, Turkey, 11 - 13 May 2017, pp.107, (Full Text)
2017
201728. Insulin Receptor Substrate (IRS) Proteins as Therapeutic Target in Cancer
Görgişen G., Gülaçar İ. M., Çetin Z.
Innovation in Medicine Summit 3, Gaziantep, Turkey, 11 - 13 May 2017, pp.101, (Full Text)
2016
201629. MUTATIONAL ANALYSIS OF AMINO TERMINAL DOMAIN OF INSULIN RECEPTOR SUBSTRATE-1 (IRS1) GENE IN GLIOBLASTOMA MULTIFORME PATIENTS
Gülaçar İ. M., Tülüce Y., Özkol H., Görgişen G., Yakut S.
6.Multidispliner Kanser Araştırma Kongresi, Konya, Turkey, 27 - 30 October 2016, pp.143, (Full Text)
2016
201630. AKT/PKB-MEDIATED PHOSPHORYLATION OF TWIST1 IS ESSENTIAL FOR TUMOR GROWTH AND METASTASIS
Pehlivanoğlu S., Görgişen G., Kahraman Dirice S., Özeş O. N.
6. Multidisipliner Kanser Araştırma Kongresi, Konya, Turkey, 27 - 30 October 2016, vol.4, pp.36-37, (Summary Text)
2016
201631. CRITICAL NODE IN DEVELOPING DIABETES AND CANCER: INSULIN RECEPTOR SUBSTRATE (IRS) PROTEINS
Görgişen G.
6. Multidisipliner Kanser Araştırma Kongresi, Konya, Turkey, 27 - 30 October 2016, vol.4, pp.16, (Full Text)
2016
201632. The Role of IRS (Insulin Receptor Substrate) Protein in Oncogenic Transformation
Görgişen G.
Innovation in Medicine Summit 2, Gaziantep, Turkey, 5 - 07 May 2016, pp.1, (Full Text)
2016
201633. Screening of Insulin Receptor Substrate 1 IRS 1 Carboxy Terminal Domain Variations in Glioblastoma Multiforme Patients
GÜLAÇAR İ. M., TÜLÜCE Y., ÖZKOL H., GÖRGİŞEN G., YAKUT UZUNER S.
Innovation in Medicine Summit-2, 5 - 07 May 2016, (Summary Text)
2015
201534. p38 MAPK Aracılı İnsülin Reseptör Substrat 1 Proteininin Serin Bölgelerinden Fosforilasyonu Hücre Proliferasyonunda ve İnsülin Direncinde Önemli Rol Oynamaktadır
Görgişen G., Yılmaz Ö., OZES O. N.
XIV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi (Uluslararası Katılımlı), Muğla, Turkey, 27 - 31 October 2015, pp.1, (Full Text)
2015
201535. Küçük Hücreli Olmayan Akciğer Tümörlerinde Meydana Gelen İnsülin Reseptör Substrat 1 Geni p.S668T VE p.D674H Değişimleri Hücre Proliferasyonunda Önemli Rol Oynamaktadır
Görgişen G., Yılmaz Ö., Cetin Z., PEHIVANOGLU S., ERDOGAN A., OZES O. N.
21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text)
2015
201536. Differential Activation and Expression of IRS1 Protein After Insulin Stimulation of Mononuclear Cells of Type 2 Diabetes Patients.
Görgişen G., CELIK F., GOKKAYA M., OZDEM S., OZEL D., BALCI M., et al.
International Symposium on Advances in Predictive & Personalized Medicine, İstanbul, Turkey, 2 - 03 April 2015, pp.1, (Full Text)
2014
201437. AKT-mediated phosphorylation is responsible for TWIST1-mediated tumor growth and metastasis
Ozes O. N., Pehivanoglu S., Ertosun G., Gorgisen G., ERİN N., Unal D., et al.
105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), California, United States Of America, 5 - 09 April 2014, vol.74, (Summary Text)
2014
201438. TWIST1 is activated by AKT/PKB- mediated phosphorylation in cancer metastasis
PEHIVANOGLU S., Görgişen G., Kahraman Dirice S., OZES O. N.
EACR- Sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress, Muğla, Turkey, 23 - 27 April 2014, pp.1, (Full Text)
2014
201439. Tip 2 Diyabetik Hastaların Mononüklear Hücrelerinden Elde Edilen İnsülin Reseptör Substrat 1 (IRS1)’ in In Vitro Fosforilasyon Düzeyleri
GOKKAYA M., CELIK F., Görgişen G., OZES O. N., OZDEM S., BALCI M.
50. Ulusal Diyabet Kongresi, Antalya, Turkey, 17 - 20 April 2014, pp.1, (Full Text)
2013
201340. Tip 2 diyabetli hastalarda insülin cevabı mononüklear hücrelerdeki insülin reseptör susbstrat 1 proteininin (IRS1) ekpresyon düzeyi ile ilişkili olabilir.
Görgişen G., GOKKAYA M., CELIK F., OZDEM S., BALCI M., OZES O. N.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi (Uluslararası Katılımlı), Aydın, Turkey, 26 - 30 October 2013, pp.1, (Full Text)
2013
201341. TWIST1 AKT/PKB-aracılı fosforilasyon ile aktive olur
PEHLIVANOGLU S., Görgişen G., OZES O. N.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi (Uluslararası Katılımlı), Aydın, Turkey, 24 - 27 October 2013, pp.1, (Full Text)
2013
201342. Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients
Görgişen G., PEHIVANOGLU S., Cetin Z., ERDOGAN A., Özeş O. N.
EMBL Cancer Genomics, Heidelberg, Germany, 23 - 27 October 2013, pp.1, (Full Text)
2013
201343. , Tip 2 diyabet hastalarının mononuclear hücrelerinden elde edilen IRS1 ‘ in in vitro fosforilasyon duzeylerinin insulin tepkiselliği için diagnostik bir gösterge olarak kullanılabilir mi?
GOKKAYA M., CELIK F., BALCI M., OZES O. N., Görgişen G., OZDEM S.
49. Ulusal Diyabet Kongresi, Antalya, Turkey, 18 - 21 April 2013, pp.1, (Full Text)
2013
201344. Clinopathologic correlation with the LCM based instability profiles for microsatellite regions in the benign to metastatic transitions of surface epithelium ovarian tumor subtypes
Görgişen G.
AACR, Washington, United States Of America, 6 - 10 April 2013, vol.73, pp.3166, (Summary Text)
2012
201245. Küçük Hücreli Olmayan Akciğer Kanser Vakalarında EGFR ve KRAS Aktivasyon Mekanizmalarından Bağımsız İndüklenmiş Onkogenik Ekspresyonlarının ve Fosforilasyonlarının Değerlendirilmesi
Görgişen G., OZES D., PEHIVANOGLU S., ERDOGAN A., DERTSIZ L., OZBILIM G., et al.
IV. Muldisipliner Kanser Araştırma Kongresi, Bursa, Turkey, 20 - 23 December 2012, pp.1, (Full Text)
2012
201246. In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness
Görgişen G., CELIK F., GOKKAYA M., BALCI M., OZDEM S., OZES O. N.
EMBO Diabetes and Obesity Symposium, Heidelberg, Germany, 24 - 28 October 2012, pp.1, (Full Text)
2012
201247. Tip 2 Diyabet Hastalarında İnsülin Reseptör Substrat 1 Proteinin in vitro Fosforilasyon Değişimi
GOKKAYA M., CELIK F., Görgişen G., BALCI M., OZES O. N., OZDEM S.
Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Turkey, 20 - 23 April 2012, pp.1, (Full Text)
2012
201248. Tip 2 Diyabet Hastalarında İn vitro Ortamda İnsülin Reseptör Substrat 1 Fosforilasyon Değişimi
GOKKAYA M., CELIK F., OZES O. N., OZDEM S., BALCI M., Görgişen G.
48. Ulusal Diyabet Kongresi, Antalya, Turkey, 12 - 15 April 2012, pp.1, (Full Text)
2011
201149. Evalution of EGFR Activation and Expression Of Proliferative Oncogenes in Patient Diagnosed with NSCLC (Non-Small Cell Lung Cancer)
Görgişen G., Pehlivanoğlu S., Özeş D., Yıldız S., Ozbilim G., Dertsiz L., et al.
International Congress of Molecular Medicine, İstanbul, Turkey, 28 - 31 December 2011, pp.1, (Full Text)
2009
200950. Mitochondrial D-Loop 16189 np alterations in epithelial ovarian tumors
Görgişen G., Alper Ö., Peştereli H., Erdoğan G., Şimşek T., Karaveli F. Ş., et al.
MedimedGen 2009, Ankara, Turkey, 28 June - 01 July 2009, pp.1, (Full Text)
2009
200951. LCM based instability profiles for the mitochondrial microsatellite regions in the borderline surface epithelium ovarian tumors
Görgişen G.
MediMedGen2009, Ankara, Turkey, 28 June - 01 July 2009, pp.1, (Full Text)
Books
2024
20241. MOLECULAR APPROACHES IN MEDICINE: PERSPECTIVES OF PARASITOLOGY AND GENETICS
Beyhan Y. E. (Editor), Görgişen G. (Editor)
Nobel Yayınevi, İstanbul, 2024
2024
20242. SPINAL MUSCULAR ATROPHY (SMA): CLINICAL CHARACTERISTICS, MOLECULAR MECHANISMS AND TREATMENT
Görgişen G.
in: MOLECULAR APPROACHES IN MEDICINE: PERSPECTIVES OF PARASITOLOGY AND GENETICS, Yunus Emre Beyhan,Gökhan Görgişen, Editor, Nobel Yayınevi, İstanbul, pp.153-166, 2024
2022
20223. BAKTERİLERDE VÜRÜLANS PROFİLLERİNİ ETKİLEYEN FAKTÖRLER VE FARKLI SICAKLIKLARDA YERSİNİA RUCKERİ ETKENİNİNİN GEN PROFİLLEME ÖRNEĞİ
Önalan Ş., Görgişen G., Ergöz B.
in: Su Ürünlerinde Modern Perspektifler, Dr. Öğr. Üyesi Boran KARATAŞ, Editor, İksad Yayınevi, Ankara, pp.135-161, 2022
Funded Projects
2024 - 2026
2024 - 2026
Mısır Koçanından Biyoteknolojik Yöntemlerle Sağlık Takviyesi Olarak Protein ve Biyoaktif Peptit Üretimi
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Öztop H. M.(Executive), Görgişen G.
2023 - 2025
2023 - 2025Nutrigenomik Kit Üretimi
KOSGEB
Gülaçar I. M. (Executive), Görgişen G. (Executive)
2023 - 2025
2023 - 2025İntestinal Epitelyal Hücre Disfonksiyon Modeli ve DSS ile İndüklenmiş Rat Ülseratif Kolit Modelinde Panoptozis Hücre Ölüm Yolağının Ülseratif Kolit Patofizyolojisindeki Öneminin Araştırılması
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Görgişen G., Çetin Z.(Executive), Altınbaş B., Bozkurt A. S., Külekçi G. D., Güngör M., et al.
2021 - 2025
2021 - 2025Functionalized tomato products (FunTomp)
H2020 Project , H2020 Other Career Development Projects
Öztop H. M., Görgişen G. (Executive)
2023 - 2024
2023 - 2024Bariatrik Cerrahi Hastalarında FTO Gen Polimorfizmlerinin Kilo Kaybı İle Arasındaki İlişki
Project Supported by Higher Education Institutions , BAP PhD
Çelik S. (Executive), Görgişen G., Şentürk E.
2022 - 2023
2022 - 2023UCP2 Ala55Val ve 866GA Polimorfizmlerinin Bariatrik Cerrahi Sonrası Kilo Verme İle İlişkisi
Project Supported by Higher Education Institutions , BAP PhD
Kaptanoğlu S. (Executive), YÜKSEK S., Görgişen G.
2021 - 2023
2021 - 2023Bitkisel Karışımlarla Zenginleştirilmiş FonksiyonelÖzellikli Hazır Toz Çay Üretimi
TUBITAK Project , 1505 - University-Industry Cooperation Support Program
Öztop H. M.(Executive), Görgişen G.
2020 - 2022
2020 - 2022Real-Time PCR Tabanlı Farmakogenetik Tanı Kitlerinin Geliştirilmesi
KOSGEB
Görgişen G. (Executive), Gülaçar İ. M. (Executive)
2020 - 2021
2020 - 2021
Meme Kanseri Hücre Hattında İnsülin Reseptör Substrat 1 IRS1 İndüklü miRNA Ekspresyon Profilinin Belirlenmesi
Project Supported by Higher Education Institutions , BAP MSc
Görgişen G. (Executive), ECER Y.
2020 - 2021
2020 - 2021Glioblastoma Multiforme' de IRS4 Proteininin Radyoterapi Üzerindeki Rolünün Belirlenmesi
Project Supported by Higher Education Institutions , BAP MSc
Görgişen G. (Executive), ARSLAN A.
2018 - 2021
2018 - 2021Van Yüzüncü Yıl Üniversitesinin Patent Potansiyelinin Araştırılması Değerlendirilmesi Patent Başvuru Sürecinin Hızlandırılması ve Fikri Sınai Mülkiyet Konusunda Sertifikalı Eğitimler Verilerek Kurumsal Farkındalık Oluşturulması
Project Supported by Higher Education Institutions , BAP Guided
Keskin S. (Executive), Yavuz H. İ., Mengeş N., Görgişen G., Görentaş N.
2018 - 2021
2018 - 2021
Özofagus kanserinde insülinbenzeri büyüme faktörü bağlayıcı protein7 (IGFBP7) promotor metilasyonunun belirlenmesi
Project Supported by Higher Education Institutions , BAP Research Project
Kaya Z. (Executive), Görgişen G., Almalı N.
2019 - 2020
2019 - 2020
IRS1 Gly972Arg ve IRS2 Gly1057Asp Polimorfizmlerinin Gastrik Kanser Gelişimi ile Arasındaki İlişki
Project Supported by Higher Education Institutions , BAP MSc
Görgişen G. (Executive), KARATAŞ U.
2019 - 2020
2019 - 2020Biyolojik ilaç kullanan psoriasis vulgaris hastalarında IL17A ve IL17F gen polimorfizmlerinin tedaviye dirençle ilişkisinin araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
Uce Özkol H. (Executive), Görgişen G., Özkol H., Tülüce Y., Savaş H., Gülaçar İ. M.
2019 - 2019
2019 - 2019İnsülin Reseptör Substrat 1 IRS1 S636 S666 ve S736 fosforilasyonları IRS1 tirozin fosforilasyonunu inhibe ederek HeLa hücrelerinin sağkalımını azaltır
Project Supported by Higher Education Institutions , BAP Other
Görgişen G. (Executive)
2018 - 2019
2018 - 2019In Vitro Ortamda İnsülin Reseptör Substrat 1 IRS1 Bağımlı Sinyal İletim Ağının Glioblastoma Multiforme Gelişimindeki Rolünün Belirlenmesi
Project Supported by Higher Education Institutions , BAP MSc
Görgişen G. (Executive), YAREN Z.
2018 - 2019
2018 - 2019Nöron dejenerasyonunda sedatif hipnotik ilaçların rolü Midazolam ve tiyopentalin yeni doğan ve erişkin sıçanlar üzerine etkileri
Project Supported by Higher Education Institutions , BAP Research Project
Soyalp C. (Executive), ÖKSÜZ E., Görgişen G., Yaşar S., Gülaçar İ. M.
2018 - 2019
2018 - 2019Farklı sıcaklıklarda gelişen Yersinia ruckeri izolatlarının virulans gen protein profillerinin belirlenmesi
Project Supported by Higher Education Institutions , BAP Research Project
Önalan Ş. (Executive), ERGÖZ B., Görgişen G.
2018 - 2019
2018 - 2019Gastrointestinal Sistem tümörlerinde genetik yatkınlık: Mide ve özofagus tümörü olan hastalarda Metilen Tetrahidrofolat Redükaz enzim polimorfizmi
Project Supported by Higher Education Institutions , BAP Research Project
Oto G. (Executive), Aras A., Özdemir H., Görgişen G., Gülaçar İ. M., Öksüz E.
2018 - 2018
2018 - 2018Bölge Spesifik İnsülin Reseptör Substrat 1 IRS1 Proteini Serin Fosforilasyonu Servikal Karsinom Hücrelerinde Proliferasyonu İnhibe Eder
Project Supported by Higher Education Institutions , BAP Other
Görgişen G. (Executive)
2017 - 2018
2017 - 2018
Türkiyenin Doğu Anadolu bölgesi populasyonunda rs1042522 ve özofagus kanseri arasındaki ilişki
Project Supported by Higher Education Institutions , BAP Other
Kaya Z. (Executive), Dülger A. C., Görgişen G., Almalı N.
2016 - 2018
2016 - 2018
Kanser Tedavisinin Yönelendirilmesinde Etkin Olan Tanı Kitlerinin Üretilmesi
Project Supported by Other Official Institutions
Gülaçar İ. M., Görgişen G. (Executive)
2016 - 2018
2016 - 2018
Serviks Kanseri Hücre Hattında İnsülin Reseptör Substrat 1 IRS1 Proteininin Translasyon Sonrası Modifikasyonlarının Hücre Proliferasyonu ve Migrasyonu Üzerine Etkilerinin Belirlenmesi
Project Supported by Higher Education Institutions , BAP Research Project
Görgişen G. (Executive), Gülaçar İ. M., Özkol H., Kaya Z., Tülüce Y.
Activities in Scientific Journals
2024 - Present
2024 - PresentMOLECULAR AND CLINICAL ONCOLOGY
Editor
2024 - Present
2024 - PresentMedicine International
Editor
2022 - Present
2022 - PresentFRONTIERS IN MEDICINE
Assistant Editor/Section Editor
2017 - Present
2017 - PresentEJM
Assistant Editor/Section Editor
2016 - Present
2016 - PresentVan Tıp Dergisi
Assistant Editor/Section Editor
Student Project
2024 - Present
2024 - Presentİnsülin Reseptör Substrat 4 Proteininin In vitro Ortamda Glioblastoma Multiforme Hücrelerinin Sağkalımı Üzerindeki Rolünün Belirlenmesi
R & D Project
Van Yüzüncü Yil University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
Memberships and Roles in Scientific Organizations
2024 - Present
2024 - PresentTıbbi Genetik Derneği Onkogenetik Komisyon Üyesi
Member of Science Committee
2022 - Present
2022 - PresentTıbbi Genetik Derneği
Member
2016 - Present
2016 - PresentEACR
Member
2016 - Present
2016 - PresentMOKAD
Member
2011 - Present
2011 - PresentTıbbi Biyoloji ve Genetik Derneği
Member
Peer Reviews in Scientific Publications
December 2019
December 2019Mehmet Akif Ersoy Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
National Scientific Refreed Journal
June 2019
June 2019Van Tıp Dergisi
National Scientific Refreed Journal
May 2019
May 2019EJM
Other Indexed Journal
April 2019
April 2019SDÜ Sağlık Bilimleri Dergisi
National Scientific Refreed Journal
February 2019
February 2019EJM
Other Indexed Journal
November 2018
November 2018Cellular and Molecular Biology
SCI Journal
September 2018
September 2018Turkish Journal of Hematology
SCI Journal
June 2018
June 2018Yuzuncu Yıl University Journal of The Institute of Natural and Applied Science
National Scientific Refreed Journal
May 2018
May 2018EJM
Other Indexed Journal
May 2018
May 2018Cellular and Molecular Biology
SCI Journal
March 2018
March 2018Cellular and Molecular Biology
SCI Journal
December 2017
December 2017Cellular and Molecular Biology
SCI Journal
November 2017
November 2017Cellular and Molecular Biology
SCI Journal
October 2017
October 2017Cellular and Molecular Biology
SCI Journal
September 2017
September 2017Journal of Molecular Histology
SCI Journal
July 2017
July 2017Celullar and Molecular Biology
SCI Journal
April 2017
April 2017Cellular and Molecular Biology
SCI Journal
April 2017
April 2017Revista Brasileira Farmacognosia
Other Indexed Journal
Scientific Project Refereeing
March 2019
March 2019TUBITAK Project
February 2019
February 2019TUBITAK Project
December 2016
December 2016Project Supported by Higher Education Institutions
Roles in Event Organizations
March 2024
March 20244th International egean Health Sciences Symposium4th International egean Health Sciences Symposium
Scientific Congress
Görgişen G.
İzmir, Turkey
September 2020
September 2020Bakterilerde biyoinformatik
Workshop Organization
Önalan Ş., Görgişen G., Taşkın B., Yavuz H. İ., Sancak T., Rişvanlı M. R., et al.
Van, Turkey
Mobility Activity
2021 - 2022
2021 - 2022Post Doc
Post Doc
Universitat Autonoma de Barcelona, Spain
Awards
July 2019
July 20192nd Best Oral Presantation
3rd International Congress on Advances in Bioscience and Biotechnology
October 2015
October 2015Prof. Dr. Altan Günalp Araştırma Ödülü İkincilik
Tıbbi Biyoloji ve Genetik Derneği
June 2015
June 2015
21. Ulusal Kanser Kongresi Sözlü Sunum Birincilik Ödülü
Radyasyon Onkolojisi Derneği, Türk Kanser Vakfı
Congress and Symposium Activities
25 July 2024 - 24 August 2024
25 July 2024 - 24 August 2024Limitless Makers 4
Invited Speaker
İstanbul-Turkey
09 July 2023 - 11 July 2023
09 July 2023 - 11 July 2023
Limetless Makers 3
Invited Speaker
Rize-Turkey
13 June 2023 - 16 June 2023
13 June 2023 - 16 June 2023
Mesleki Eğitimin Geleceği
Session Moderator
Hakkari-Turkey
01 September 2019 - 01 September 2019
01 September 2019 - 01 September 2019
Eurasian Congress on Molecular Biotechnology
Invited Speaker
Trabzon-Turkey
01 September 2019 - 01 September 2019
01 September 2019 - 01 September 2019
Eurasian Congress on Molecular Biotechnology
Moderator
Trabzon-Turkey
01 June 2019 - 01 June 2019
01 June 2019 - 01 June 2019International Symposium on Academic Studies in Health and Sport Sciences
Session Moderator
Ankara-Turkey
01 May 2018 - 01 May 2018
01 May 2018 - 01 May 2018
1. International Health Science and Life Congress
Invited Speaker
Burdur-Turkey
01 October 2016 - 01 October 2016
01 October 2016 - 01 October 2016
6. Multidisipliner Kanser Araştırmaları Kongresi
Invited Speaker
Konya-Turkey
01 May 2016 - 01 May 2016
01 May 2016 - 01 May 2016Innovation in Medicine Summit 2
Invited Speaker
Gaziantep-Turkey
Scholarships
2021 - 2022
2021 - 2022TÜBİTAK 2219
TUBITAK
2009 - 2015
2009 - 2015TÜBİTAK BİDEB Doktora Bursu
TUBITAK
2012 - 2012
2012 - 2012EMBO Travel Grant
Other International Organizations
2007 - 2009
2007 - 2009TÜBİTAK BİDEB Y.Lisans Bursu
TUBITAK
Citations
Total Citations (WOS): 87
h-index (WOS): 6
Scientific Research / Working Group Memberships
2023 - Present
2023 - PresentCost Action- Ca1140
https://www.cost.eu/actions/CA21140/#tabs+Name:Main%20Contacts%20and%20Leadership
Académie de Lyon, France
2023 - Present
2023 - Present